Literature DB >> 28004111

COL11A1 is overexpressed in gastric cancer tissues and regulates proliferation, migration and invasion of HGC-27 gastric cancer cells in vitro.

Aiqing Li1, Jun Li1, Jinping Lin2, Wei Zhuo3, Jianmin Si1.   

Abstract

The role of COL11A1 in carcinogenesis is increasingly recognized. However, the biological role and potential mechanisms of COL11A1 in gastric cancer have not been elucidated. In the present study, the COL11A1 mRNA expression in 57 patients with gastric cancer was measured by reverse transcription quantitative PCR (RT-qPCR), and the biological effects of COL11A1 suppression were determined using MTS, monolayer colony formation, flow cytometry and Transwell assays. In addition, the potential molecular mechanisms of COL11A1 in gastric cancer were analyzed by western blotting and cDNA microarray analysis. Compared with matched adjacent non-tumor tissue, COL11A1 mRNA was significantly overexpressed in tumor tissue and was positively related to age, tumor invasion depth, tumor size and lymph node positivity. Moreover, in vitro experiments demonstrated that COL11A1 suppression by short hairpin RNA (shRNA) significantly inhibited the proliferation, migration and invasion of HGC-27 cells and that COL11A1 suppression promoted cell apoptosis, induced G1-phase cell cycle arrest and led to a significant downregulation of cyclin D1 and upregulation of p21 and cleaved caspase-3. In addition, the cDNA microarray analysis of HGC-27 cells with and without COL11A1 suppression indicated that COL11A1 may regulate multiple genes responsible for cell growth and/or invasion, including downregulation of CDK6, TIAM1, ITGB8 and WNT5A and upregulation of RGS2 and NEFL following suppression of COL11A1 expression in HGC-27 cells, validated with RT-qPCR assays. Taken together, our findings demonstrate that COL11A1 might be an oncogene in GC and is a promising therapeutic target in cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28004111     DOI: 10.3892/or.2016.5276

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  18 in total

1.  Identification of potential core genes in metastatic renal cell carcinoma using bioinformatics analysis.

Authors:  Chunsheng Li; Ting Shao; Guochang Bao; Zhiming Gao; Yinglang Zhang; Honglin Ding; Wei Zhang; Fengjun Liu; Changgang Guo
Journal:  Am J Transl Res       Date:  2019-11-15       Impact factor: 4.060

2.  Characterization of Tumor Mutation Burden-Based Gene Signature and Molecular Subtypes to Assist Precision Treatment in Gastric Cancer.

Authors:  Cheng Wei; Minzhe Li; Shaofeng Lin; Jun Xiao
Journal:  Biomed Res Int       Date:  2022-05-13       Impact factor: 3.246

3.  SPP1 facilitates cell migration and invasion by targeting COL11A1 in lung adenocarcinoma.

Authors:  Xuan Yi; Linlin Luo; Yanzhen Zhu; Hong Deng; Huitian Liao; Yang Shen; Yan Zheng
Journal:  Cancer Cell Int       Date:  2022-10-20       Impact factor: 6.429

4.  The KN Motif and Ankyrin Repeat Domains 1/CXXC Finger Protein 5 Axis Regulates Epithelial-Mesenchymal Transformation, Metastasis and Apoptosis of Gastric Cancer via Wnt Signaling.

Authors:  Xin Chen; Xiaodong Wang; Lanjuan Yi; Ying Song
Journal:  Onco Targets Ther       Date:  2020-07-28       Impact factor: 4.147

5.  Identification of crucial noncoding RNAs and mRNAs in hypertrophic scars via RNA sequencing.

Authors:  Xiaodong Li; Zeliang He; Julei Zhang; Yan Han
Journal:  FEBS Open Bio       Date:  2021-05-12       Impact factor: 2.693

6.  An integrated meta-analysis approach to identifying medications with potential to alter breast cancer risk through connectivity mapping.

Authors:  Gayathri Thillaiyampalam; Fabio Liberante; Liam Murray; Chris Cardwell; Ken Mills; Shu-Dong Zhang
Journal:  BMC Bioinformatics       Date:  2017-12-21       Impact factor: 3.169

7.  A core matrisome gene signature predicts cancer outcome.

Authors:  Arseniy E Yuzhalin; Tomas Urbonas; Michael A Silva; Ruth J Muschel; Alex N Gordon-Weeks
Journal:  Br J Cancer       Date:  2018-01-23       Impact factor: 7.640

8.  Fibroblast Growth Factor-14 Acts as Tumor Suppressor in Lung Adenocarcinomas.

Authors:  Kati Turkowski; Frederik Herzberg; Stefan Günther; David Brunn; Andreas Weigert; Michael Meister; Thomas Muley; Mark Kriegsmann; Marc A Schneider; Hauke Winter; Michael Thomas; Friedrich Grimminger; Werner Seeger; Soni Savai Pullamsetti; Rajkumar Savai
Journal:  Cells       Date:  2020-07-22       Impact factor: 6.600

9.  Integrated bioinformatics analysis of key genes involved in progress of colon cancer.

Authors:  Haojie Yang; Jiong Wu; Jingjing Zhang; Zhigang Yang; Wei Jin; Ying Li; Lei Jin; Lu Yin; Hua Liu; Zhenyi Wang
Journal:  Mol Genet Genomic Med       Date:  2019-02-11       Impact factor: 2.183

Review 10.  Molecular patterns of cancer colonisation in lymph nodes of breast cancer patients.

Authors:  Gaurav Chatterjee; Trupti Pai; Thomas Hardiman; Kelly Avery-Kiejda; Rodney J Scott; Jo Spencer; Sarah E Pinder; Anita Grigoriadis
Journal:  Breast Cancer Res       Date:  2018-11-20       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.